“Current estimates say that approximately 300,000 people come down with Lyme disease every year, and that’s probably an underestimate,” said Dr. Joel Tabb, president and co-founder of Ionica Sciences in Weill Hall’s McGovern Center at Cornell. Dr. Tabb’s team at Ionica Sciences has developed a new and improved diagnostic test for Lyme disease. Read more >>
The test would quickly confirm the presence of the bacteria that causes Lyme, rather than waiting for weeks for a patient’s body to develop the antibodies that current tests detect, Cornell said.
“It’s a major breakthrough, ”said Joel Tabb, president and co-founder of Ionica Sciences, the private company working on the test. Ionica is housed at Cornell’s McGovern Center, which serves as an incubator for businesses. Read more >>
The drawn-out process for diagnosing Lyme disease could become a thing of the past – good news for the thousands of people each year who get the tick-borne illness. A new detection test created by Ionica Sciences – located at Cornell’s McGovern Center life sciences incubator – has been sparked by a FuzeHub grant to begin moving from the laboratory bench into approvals, production and doctors’ offices. Read more >>
A non-profit organization has awarded more than $400,000 worth of grants to manufacturers and colleges across New York state, including Ionica Sciences Read more >>